Additionally, our findings suggest that the small molecule ROR1 inhibitor, PGG, selectively targets ROR1-expressing cancer cells and suppresses proliferation, anti-apoptosis, migration, invasion, and cell cycle progression. The gene discussed is ROR1; the disease is cancer.